BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7637268)

  • 1. Favorable course of steroid-responsive nephrotic children with mild initial attack.
    Hiraoka M; Takeda N; Tsukahara H; Kimura K; Takagi K; Hayashi S; Kato E; Ohta K; Sudo M
    Kidney Int; 1995 May; 47(5):1392-3. PubMed ID: 7637268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High incidence of initial and late steroid resistance in childhood nephrotic syndrome.
    Kim JS; Bellew CA; Silverstein DM; Aviles DH; Boineau FG; Vehaskari VM
    Kidney Int; 2005 Sep; 68(3):1275-81. PubMed ID: 16105061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selectivity of proteinuria and steroid response in idiopathic nephrotic syndrome.
    Chuan PL; Kok LY
    J Singapore Paediatr Soc; 1979; 21(1-2):78-84. PubMed ID: 548639
    [No Abstract]   [Full Text] [Related]  

  • 4. Differential protein clearances and response to treatment in Nigerian nephrotic children.
    Adeniyi A; Hendrickse RG; Soothill JF
    Arch Dis Child; 1976 Sep; 51(9):691-6. PubMed ID: 793539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
    El-Husseini A; El-Basuony F; Mahmoud I; Sheashaa H; Sabry A; Hassan R; Taha N; Hassan N; Sayed-Ahmad N; Sobh M
    Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow-up study of IgM associated nephrotic syndrome patients: clinical outcome and prognostic indicators.
    Kurathong P; Jesdapatarakul S
    J Med Assoc Thai; 2000 Mar; 83(3):315-24. PubMed ID: 10808687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent hypercholesterolaemia in frequently relapsing steroid-responsive nephrotic syndrome.
    Tsukahara H; Haruki S; Hiraoka M; Hori C; Sudo M
    J Paediatr Child Health; 1997 Jun; 33(3):253-5. PubMed ID: 9259304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Multicenter survey of diagnostic and therapeutic status in Chinese childhood patients with steroid-sensitive, relaping/steroid-dependent nephrotic syndrome].
    Working Group For National Survey On Status Of Diagnosis And Treatment Of Childhood Renal Diseases
    Zhonghua Er Ke Za Zhi; 2014 Mar; 52(3):194-200. PubMed ID: 24824389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High serum adiponectin levels during steroid-responsive nephrotic syndrome relapse.
    Bakkaloglu SA; Soylemezoglu O; Buyan N; Funahashi T; Elhan AH; Peru H; Fidan K; Yilmaz S; Hasanoglu E
    Pediatr Nephrol; 2005 Apr; 20(4):474-7. PubMed ID: 15690190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of prednisolone in children with the nephrotic syndrome.
    Rostin M; Barthe P; Houin G; Alvinerie M; Bouissou F
    Pediatr Nephrol; 1990 Sep; 4(5):470-3. PubMed ID: 2242307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steroid response pattern in Indian children with nephrotic syndrome.
    Gulati S; Kher V; Sharma RK; Gupta A
    Acta Paediatr; 1994 May; 83(5):530-3. PubMed ID: 8086733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclosporin in the treatment of steroid-responsive and steroid-resistant nephrotic syndrome in adults.
    Maher ER; Sweny P; Chappel M; Varghese Z; Moorhead JF
    Nephrol Dial Transplant; 1988; 3(6):728-32. PubMed ID: 3147413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium dodecyl sulphate polyacrylamide gel electrophoresis of urinary proteins in steroid-responsive and steroid-resistant nephrotic syndrome in children.
    Ramjee G; Coovadia HM; Adhikari M
    Pediatr Nephrol; 1994 Dec; 8(6):653-6. PubMed ID: 7696097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Older boys benefit from higher initial prednisolone therapy for nephrotic syndrome. The West Japan Cooperative Study of Kidney Disease in Children.
    Hiraoka M; Tsukahara H; Haruki S; Hayashi S; Takeda N; Miyagawa K; Okuhara K; Suehiro F; Ohshima Y; Mayumi M
    Kidney Int; 2000 Sep; 58(3):1247-52. PubMed ID: 10972687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous cyclophosphamide in steroid-resistant nephrotic syndrome.
    Bajpai A; Bagga A; Hari P; Dinda A; Srivastava RN
    Pediatr Nephrol; 2003 Apr; 18(4):351-6. PubMed ID: 12700961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperlipidemia in childhood idiopathic nephrotic syndrome during initial remission and relapse.
    Mahmud S; Jahan S; Hossain MM
    Mymensingh Med J; 2011 Jul; 20(3):402-6. PubMed ID: 21804502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporine in the treatment of childhood idiopathic steroid resistant nephrotic syndrome: a single centre experience in Nigeria.
    Ladapo TA; Esezobor CI; Lesi FE
    Pan Afr Med J; 2016; 25():258. PubMed ID: 28293374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin converting enzyme inhibitors for reduction of proteinuria in children with steroid-resistant nephrotic syndrome.
    Milliner DS; Morgenstern BZ
    Pediatr Nephrol; 1991 Sep; 5(5):587-90. PubMed ID: 1911144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term steroid treatment and growth: a study in steroid-dependent nephrotic syndrome.
    Simmonds J; Grundy N; Trompeter R; Tullus K
    Arch Dis Child; 2010 Feb; 95(2):146-9. PubMed ID: 20172895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum glomerular permeability activity in patients with podocin mutations (NPHS2) and steroid-resistant nephrotic syndrome.
    Carraro M; Caridi G; Bruschi M; Artero M; Bertelli R; Zennaro C; Musante L; Candiano G; Perfumo F; Ghiggeri GM
    J Am Soc Nephrol; 2002 Jul; 13(7):1946-52. PubMed ID: 12089392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.